CPIRT Center News
People diagnosed with chronic obstructive pulmonary disease often experience markedly different symptoms, disease trajectories, and responses to treatment. To better understand this variability, a new study from researchers at Yale School of Medicine used single-cell sequencing technology alongside complementary spatial transcriptomic and proteomic analyses to examine lung tissue from people with COPD in unprecedented detail.
- December 08, 2025
A new study from Yale researchers identifies an epithelial-immune signaling pathway crucial to the lung’s injury-repair process. When this signaling is altered, the study shows, it may help push the lung toward fibrosis.
- September 03, 2025
A new Yale-led study sheds light on how asthma behaves differently in males and females, both in symptoms and at the level of gene expression.
- August 27, 2025
The Yale Pepper Older Americans Independence Center (OAIC) is soliciting letters of intent from full-time Yale faculty members with interests and expertise relevant to aging research for the Research Education Core (REC) and Pilot Exploratory Study Core (PESC) awards.
- August 05, 2025
A new collaborative program, the Ugandan Registry of RMDs in HIV (GEMINI), aims to improve the study of HIV and rheumatic and musculoskeletal diseases (RMDs) in Uganda.
- July 03, 2025Source: Yale News
In a new study, Yale researchers develop a method that has the potential to cure cystic fibrosis prior to birth.
- June 11, 2025
Two new YSPH research studies look at health care practices in China and the impact of pollution and high temperatures on children's mental health.
- May 06, 2025
Congratulations to the Yale Department of Internal Medicine faculty members who were recently promoted, appointed, or reappointed.
- April 16, 2025Source: Yale News
A method developed by Yale scientists helps reveal how antibacterial agents interact with their host cells—a process that could boost a host of applications that benefit society.
- April 03, 2025
A novel decentralized clinical trial found that Paxlovid was ineffective in alleviating Long COVID symptoms but underscored the importance of a patient-centered approach.